|
KAPA Kairos Pharma Ltd 1962011 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,388,000.00 |
| Balance Sheet |
|
Current Assets
|
$3,174,000.00 |
|
Assets
|
$4,456,000.00 |
|
Current Liabilities
|
$265,000.00 |
|
Liabilities
|
$992,000.00 |
|
Equity
|
$4,191,000.00 |
|
Shares Out
|
21423300.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,048,000.00 |
| Market Analysis |
Market Cap
|
$6,426,990.00 |
|
Price
|
$0.30 |
|
BVPS
|
0.20 |
|
PB
|
1.50 |
|
EPS
|
-0.06 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:01 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:51 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KAPA documents filed with the SEC.
KAPA Filings
Clear
